Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Best Melanotan-1 for Photoprotection: Quality Comparison

When evaluating Melanotan-1 sources for photoprotection research, quality metrics determine whether the peptide performs as intended or introduces confounding variables. The table below compares critical specifications across sourcing tiers. HPLC Purity ≥98% w

This comparison does not assign a generated winner or score.

  • When evaluating Melanotan-1 sources for photoprotection research, quality metrics determine whether the peptide performs as intended or introduces confounding variables. The table below compares critical specifications across sourcing tiers.
  • HPLC Purity
  • ≥98% with batch-specific COA
  • 90–95% (claimed, often unverified)
  • 70–90% or undisclosed
  • Research-grade purity is non-negotiable for reproducible MC1R activation. Impurities below 95% introduce deletion sequences that compete for receptor binding without triggering melanogenesis
  • Mass Spectrometry Verification
  • Provided with exact m/z ratio
  • Rarely provided
  • Never provided
  • MS confirms the peptide contains 13 amino acids at expected molecular weight. Absence of MS data means you cannot verify you received afamelanotide
  • Amino Acid Sequence Control
  • Fmoc-SPPS with stereochemistry verification (D-Phe at position 7)
  • Standard SPPS, stereochemistry not always controlled
  • Unknown synthesis method
  • D-phenylalanine at position 7 is essential for protease resistance and receptor selectivity. L-Phe substitution reduces half-life by 80%
  • Storage & Handling
  • Lyophilized at −20°C, desiccated, light-protected
  • Variable. Often room temperature during shipping
  • No cold chain documentation
  • Peptide stability degrades rapidly above −15°C. Uncontrolled shipping temperatures cause oxidative damage before the product arrives
  • Reconstitution Guidance
  • Bacteriostatic water protocols with stability data
  • Generic instructions
  • None provided
  • Incorrect reconstitution (wrong diluent pH, incorrect concentration) causes aggregation and loss of bioactivity within 72 hours
  • Batch Consistency
  • Small-batch synthesis, <2% variance between batches
  • Large-scale production, 5–10% variance common
  • Unknown or single unverified batch
  • Reproducibility across experiments requires batch-to-batch consistency. Variance above 3% invalidates comparative studies
More references

Related material